Evidence map›Paper›PMID 32064154›Full record

ArticleAmerican journal of cancer research2020

BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.

Kunpeng Liu, Qingan Yu, Hao Li, Changming Xie, Yaohua Wu, Dakun Ma, Ping Sheng, Wenjie Dai, Hongchi Jiang

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Non-Apoptotic Programmed Cell Death in Thyroid Diseases.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kunpeng LiuDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Qingan YuDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Hao LiDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Changming XieDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Yaohua WuDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Dakun MaDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Ping ShengDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Wenjie DaiDepartment of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Hongchi JiangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is the most common cancer of the endocrine system, which is usually associated with a favorable therapeutic response and prognosis. However, metastatic spreading occurs in around 5% of the PTC patients. Identification of molecular markers could early predict the metastatic potential, which is essential for reducing the patient's overtreatment. Baculoviral IAP Repeat Containing 7 (BIRC7) is an inhibitor of apoptosis protein (IAP) family gene that is known to be linked to tumor progression, but its role in the setting of PTC metastasis remains unknown. This study, therefore, aims to explore the role of BIRC7 in the metastasis and autophagy of PTC and elucidate its underlying molecular mechanisms. BIRC7 expression was assessed in fresh samples of human PTC and normal tissues via qRT-PCR and immunohistochemistry. In addition, BIRC7 was overexpressed and silenced in PTC cell lines followed by transmission electron microscopy, western blotting, immunofluorescence microscopy, wound healing and invasion assays. We further explored the relevance of BIRC7

Indexed as

autophagyBIRC7EMTmetastasispapillary thyroid carcinoma

Identifiers

PMID32064154
PMCPMC7017743
OpenAlexW3013043182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.